tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

SRRK Stock Latest News

Raising Conviction on Scholar Rock: Dual Supply Chain and Broad Apitegromab Adoption Underpin Buy Rating and Higher Target
RatingsRaising Conviction on Scholar Rock: Dual Supply Chain and Broad Apitegromab Adoption Underpin Buy Rating and Higher Target
10d ago
SRRK
Scholar Rock price target raised to $58 from $44 at H.C. Wainwright
PremiumThe Fly
Scholar Rock price target raised to $58 from $44 at H.C. Wainwright
10d ago
SRRK
Scholar Rock price target raised to $50 from $49 at BofA
PremiumThe Fly
Scholar Rock price target raised to $50 from $49 at BofA
22d ago
SRRK
Scholar Rock: Apitegromab Manufacturing Resolution and Pipeline Expansion Underpin Buy-Rated Risk-Reward Profile
PremiumRatings
Scholar Rock: Apitegromab Manufacturing Resolution and Pipeline Expansion Underpin Buy-Rated Risk-Reward Profile
22d ago
SRRK
Scholar Rock Details 2026 Strategy and Regulatory Priorities
PremiumCompany Announcements
Scholar Rock Details 2026 Strategy and Regulatory Priorities
23d ago
8K
SRRK
Scholar Rock initiated with a Buy at Citi
PremiumThe FlyScholar Rock initiated with a Buy at Citi
27d ago
SRRK
Buy/High Risk: Apitegromab’s Differentiated SMA Profile and Expanding Neuromuscular Upside Support Significant Re-Rating Potential
Premium
Ratings
Buy/High Risk: Apitegromab’s Differentiated SMA Profile and Expanding Neuromuscular Upside Support Significant Re-Rating Potential
27d ago
SRRK
Scholar Rock initiated with a Buy at UBS
Premium
The Fly
Scholar Rock initiated with a Buy at UBS
28d ago
SRRK
Scholar Rock price target raised to $52 from $45 at Barclays
PremiumThe Fly
Scholar Rock price target raised to $52 from $45 at Barclays
2M ago
SRRK
Scholar Rock Faces FDA Warning, Plans 2026 Launch
PremiumCompany Announcements
Scholar Rock Faces FDA Warning, Plans 2026 Launch
2M ago
8K
SRRK
Scholar Rock price target raised to $47 from $46 at JPMorgan
PremiumThe Fly
Scholar Rock price target raised to $47 from $46 at JPMorgan
3M ago
SRRK
Scholar Rock initiated with an Outperform at Wolfe Research
PremiumThe Fly
Scholar Rock initiated with an Outperform at Wolfe Research
3M ago
SRRK
Scholar Rock price target raised to $45 from $44 at Barclays
PremiumThe FlyScholar Rock price target raised to $45 from $44 at Barclays
3M ago
SRRK
Scholar Rock’s Earnings Call: Optimism Amid Regulatory Challenges
Premium
Company Announcements
Scholar Rock’s Earnings Call: Optimism Amid Regulatory Challenges
3M ago
SRRK
Buy Rating for Scholar Rock Holdings Driven by Strategic Preparations for Apitegromab’s Market Launch
Premium
Ratings
Buy Rating for Scholar Rock Holdings Driven by Strategic Preparations for Apitegromab’s Market Launch
3M ago
SRRK
Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!
PremiumMarket News
Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!
3M ago
DIA
MRK
Scholar Rock Advances SMA Treatment Amid Financial Losses
PremiumCompany Announcements
Scholar Rock Advances SMA Treatment Amid Financial Losses
3M ago
SRRK
Positive Outlook for Scholar Rock: Strong Cash Position and FDA Alignment Boost Buy Rating
PremiumRatings
Positive Outlook for Scholar Rock: Strong Cash Position and FDA Alignment Boost Buy Rating
3M ago
SRRK
Strategic Moves and Financial Stability Bolster Scholar Rock’s Buy Rating
PremiumRatings
Strategic Moves and Financial Stability Bolster Scholar Rock’s Buy Rating
3M ago
SRRK
Scholar Rock price target raised to $50 from $45 at BMO Capital
PremiumThe FlyScholar Rock price target raised to $50 from $45 at BMO Capital
3M ago
SRRK
Midday Fly By: Walmart names new CEO, Merck acquires Cidara
Premium
The Fly
Midday Fly By: Walmart names new CEO, Merck acquires Cidara
3M ago
HD
NU
Scholar Rock rises 25.3%
Premium
The Fly
Scholar Rock rises 25.3%
3M ago
SRRK

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >